Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas.

Authors: Yinghui Zhou, William M. Rideout III, Tong Zi, Angela Bressel, Shailaja Reddypalli, Rebecca Rancourt, Jin-Kyeung Woo, James W. Horner, Lynda Chin, M. Isabel Chiu, Marcus Bosenberg, Tyler Jacks, Steven C. Clark, Ronald A. DePinho, Murray O. Robinson, Joerg Heyer. Click here for link to article.